Literature DB >> 28264911

Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.

Chun-Peng Liao1, Leng-Ying Chen1, Andrea Luethy1, Youngsoo Kim2, Kian Kani1, A Robert MacLeod2, Mitchell E Gross3.   

Abstract

Androgen receptor (AR) regulation pathways are essential for supporting the growth and survival of prostate cancer cells. Recently, sub-populations of prostate cancer cells have been identified with stem cell features and are associated with the emergence of treatment-resistant prostate cancer. Here, we explored the function of AR in prostate cancer-associated fibroblasts (CAFs) relative to growth and stem cell-associated characteristics. CAFs were isolated from the murine cPten-/-L prostate cancer model and cultured with human prostate cancer epithelial (hPCa) cells. A murine-specific AR antisense oligonucleotide (ASO) was used to suppress the expression of AR in the CAF cells. CAFs express low, but significant levels of AR relative to fibroblasts derived from non-malignant tissue. CAFs promoted growth and colony formation of hPCa cells, which was attenuated by the suppression of AR expression. Surprisingly, AR-depleted CAFs promoted increased stem cell marker expression in hPCa cells. Interferon gamma (IFN-γ) and macrophage colony-stimulating factor (M-CSF) were increased in AR-depleted CAF cells and exhibited similar effects on stem cell marker expression as seen in the CAF co-culture systems. Clinically, elevated IFN-γ expression was found to correlate with histologic grade in primary prostate cancer samples. In summary, AR and androgen-dependent signaling are active in CAFs and exert significant effects on prostate cancer cells. IFN-γ and M-CSF are AR-regulated factors secreted by CAF cells, which promote the expression of stem cell markers in prostate cancer epithelial cells. Understanding how CAFs and other constituents of stromal tissue react to anti-cancer therapies may provide insight into the development and progression of prostate cancer.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  androgen receptor; cancer-associated fibroblast; prostate cancer; stroma

Mesh:

Substances:

Year:  2017        PMID: 28264911      PMCID: PMC5453797          DOI: 10.1530/ERC-16-0138

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  50 in total

1.  Impact of immunogenetic polymorphisms in bone marrow failure syndromes.

Authors:  B Serio; C Selleri; J P Maciejewski
Journal:  Mini Rev Med Chem       Date:  2011-06       Impact factor: 3.862

Review 2.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

3.  Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Authors:  C Huggins; C V Hodges
Journal:  CA Cancer J Clin       Date:  1972 Jul-Aug       Impact factor: 508.702

4.  Molecular classification of prostate cancer using curated expression signatures.

Authors:  Elke K Markert; Hideaki Mizuno; Alexei Vazquez; Arnold J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

Authors:  Gennadi V Glinsky; Olga Berezovska; Anna B Glinskii
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 6.  Biology and action of colony--stimulating factor-1.

Authors:  E R Stanley; K L Berg; D B Einstein; P S Lee; F J Pixley; Y Wang; Y G Yeung
Journal:  Mol Reprod Dev       Date:  1997-01       Impact factor: 2.609

7.  Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Authors:  Chun-Peng Liao; Helty Adisetiyo; Mengmeng Liang; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

Review 8.  Refining the role for adult stem cells as cancer cells of origin.

Authors:  Andrew C White; William E Lowry
Journal:  Trends Cell Biol       Date:  2014-09-18       Impact factor: 20.808

9.  AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.

Authors:  David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

10.  The role of androgen receptor mutations in prostate cancer progression.

Authors:  G N Brooke; C L Bevan
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more
  9 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.

Authors:  Andrea Clocchiatti; Soumitra Ghosh; Maria-Giuseppina Procopio; Luigi Mazzeo; Pino Bordignon; Paola Ostano; Sandro Goruppi; Giulia Bottoni; Atul Katarkar; Mitchell Levesque; Peter Kölblinger; Reinhard Dummer; Victor Neel; Berna C Özdemir; G Paolo Dotto
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 3.  Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.

Authors:  Tu-Xiong Huang; Xin-Yuan Guan; Li Fu
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

4.  Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.

Authors:  Zhen-Fei Wang; Da-Guang Ma; Zhe Zhu; Yong-Ping Mu; Yong-Yan Yang; Li Feng; Hao Yang; Jun-Qing Liang; Yong-Yan Liu; Li Liu; Hai-Wen Lu
Journal:  World J Gastroenterol       Date:  2017-12-28       Impact factor: 5.742

5.  Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model.

Authors:  Kerstin Junker; Matthias Saar; Johannes Linxweiler; Turkan Hajili; Christina Körbel; Carolina Berchem; Philip Zeuschner; Andreas Müller; Michael Stöckle; Michael D Menger
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 6.  Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy.

Authors:  Jenniffer Linares; Juan A Marín-Jiménez; Jordi Badia-Ramentol; Alexandre Calon
Journal:  Front Cell Dev Biol       Date:  2021-01-22

Review 7.  Fibroblasts in cancer dormancy: foe or friend?

Authors:  Li Dai; Mao Li; Wei-Long Zhang; Ya-Jie Tang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cancer Cell Int       Date:  2021-03-26       Impact factor: 5.722

Review 8.  New Insights and Emerging Therapeutic Approaches in Prostate Cancer.

Authors:  Fabrizio Licitra; Pia Giovannelli; Marzia Di Donato; Alessandra Monaco; Giovanni Galasso; Antimo Migliaccio; Gabriella Castoria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-11       Impact factor: 5.555

Review 9.  Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.

Authors:  Osama S Mohammad; Michael D Nyquist; Michael T Schweizer; Stephen P Balk; Eva Corey; Stephen Plymate; Peter S Nelson; Elahe A Mostaghel
Journal:  Cancers (Basel)       Date:  2017-12-06       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.